O32.SI - Olam International Limited

SES - SES Delayed Price. Currency in SGD
1.74
+0.01 (+0.58%)
As of 3:20PM SGT. Market open.
Stock chart is not supported by your current browser
Previous close1.73
Open1.72
Bid1.74 x 0
Ask1.75 x 0
Day's range1.68 - 1.75
52-week range1.68 - 2.50
Volume511,800
Avg. volume739,698
Market cap5.54B
Beta (3Y monthly)0.82
PE ratio (TTM)11.15
EPS (TTM)0.16
Earnings date14 Nov 2018
Forward dividend & yield0.07 (4.02%)
Ex-dividend date2018-08-20
1y target est2.19
  • The Wall Street Journal2 months ago

    [$$] Cocoa Exporters Pull Buyers From Cameroon Region After Threats

    YAOUNDÉ, Cameroon—Cameroon’s two main cocoa exporters have withdrawn their buyers from the southwest region following threats and harassment from secessionist groups, company workers said Friday. Neither Cargill’s Telcar Cocoa Ltd., which accounts for 27% of the nation’s cocoa exports, nor Olamcam, a unit of Singapore’s Olam International that ships nearly 21% of Cameroon’s beans, would comment on the move from the key cocoa-growing region. Company workers told The Wall Street Journal that secessionist splinter groups had demanded cocoa exporters pay them 5 million Central African francs ($8,900) to operate in southwestern Cameroon.

  • Can Olam International Limited’s (SGX:O32) ROE Continue To Surpass The Industry Average?
    Simply Wall St.5 months ago

    Can Olam International Limited’s (SGX:O32) ROE Continue To Surpass The Industry Average?

    The content of this article will benefit those of you who are starting to educate yourself about investing in the stock market and want to begin learning the link betweenRead More...

  • Olam gets US$163m loan from ADB and JICA
    Singapore Business Review8 months ago

    Olam gets US$163m loan from ADB and JICA

    The proceeds will be used mainly on Café Outspan Vietnam Limited. Olam International secured medium term financing facilities worth US$163m from the Asian Development Bank (ADB) and Japan International Cooperation Agency (JICA). According to an announcement, the facilities consist of two tranches: a US$83m, five-year facility and a US$80m, seven-year facility for Café Outspan Vietnam Limited (COVL), a wholly owned subsidiary of Olam.

  • Wilmar buys 50% of investment holder from Olam for $194.35m
    Singapore Business Review8 months ago

    Wilmar buys 50% of investment holder from Olam for $194.35m

    Following the completion of the acquisition, Nauvu is now a wholly-owned subsidiary of Wilmar. Wilmar International’s subsidiary Wilmar Resources Pte Ltd (WRPL) bought a 50% equity interest in Nauvu Investments ...

  • Chart of the Day: Temasek's major stock investments yielded 8.1%
    Singapore Business Review8 months ago

    Chart of the Day: Temasek's major stock investments yielded 8.1%

    Its investments in Keppel paid off the largest at 12.8%. This chart from the Singapore Exchange (SGX) shows that Temasek Holdings’ investments in six major stocks listed for over 20 years had average annualised ...

  • Olam 2017 profits grew 65.3% to $580.74m
    Singapore Business Review9 months ago

    Olam 2017 profits grew 65.3% to $580.74m

    Its sales volume rose 56.3%, led by growth in grains and edible oils. It was a good harvest for Olam International as its profits grew 65.3% YoY from $351.31m to $580.74m in 2017. In Q4, profits also showed growth and rose 159.3% to $265.15m.

  • Olam bags $148.26m from farmland sale
    Singapore Business Review11 months ago

    Olam bags $148.26m from farmland sale

    It sold 5,100 acres of a Californian farmland. Olam International Limited (Olam) bagged $148.26m (US$110m) from the sale of its farmland assets in California. According to a press release, it completed ...

  • Olam International's profits up 17.5% to $24.1m in Q3
    Singapore Business Reviewlast year

    Olam International's profits up 17.5% to $24.1m in Q3

    Sales volume grew 44.4% in nine months. Olam International reaps its harvest as its profits grew 17.5% YoY from $20.5m to $24.1m in Q3. According to its financial statement, revenue increased by 42.7% YoY to $6.71b, whilst gain in fair value of its biological assets widened dropped by 80.9% to $0.5m.